Skip to main content
. 2026 Apr 7;18(7):1175. doi: 10.3390/cancers18071175
RB Retinoblastoma
CDK Cyclin dependent kinase
CDK4/6i Cyclin dependent kinase 4/6 inhibitors
PARPi Poly (ADP-ribose) polymerase inhibitors
CIN Chromosomal instability
BETi Bromodomain and extraterminal domain inhibitors
DOX Doxorubicin
STS Soft tissue sarcoma
PFS Progression free survival
TNBC Triple negative breast cancer
DREAM Dimerization partner, RB-like, E2F, and the multi-vulval class B
HDACs Histone deacetylases
CHR Cell-cycle gene homology regions
ESC Embryonic stem cell
CSC Cancer stem cells
EMT Epithelial-mesenchymal transition
DSB Double-strand breaks
NHEJ Non-homologous end joining
HR Homologous recombination
ER Estrogen receptor
5-FU 5-Fluorouracil
CRISPR Clustered regularly interspaced short palindromic repeats